Durable remission achieved in pediatric patients with <i>TCF3-HLF</i>-positive relapsed / refractory B-cell acute lymphoblastic leukemia by dual CD19 and CD22-targeted chimeric antigen receptor T-cell therapy
Authors
- Xiaomin Yang (ORCID: https://orcid.org/0000-0001-9126-9280)
- Song Lili (ORCID: https://orcid.org/0000-0002-2633-4645)
- Meng Su (ORCID: https://orcid.org/0000-0001-6558-8712)
- Lixia Ding
- Hua Zhu (ORCID: https://orcid.org/0000-0002-3878-2672)
- Xinyu Wan (ORCID: https://orcid.org/0000-0001-7538-0034)
- Benshang Li
- Yanjing Tang
- Yue Li (ORCID: https://orcid.org/0000-0003-1557-3568)
- Xiang Wang (ORCID: https://orcid.org/0000-0002-0913-0501)
- Jing Chen (ORCID: https://orcid.org/0000-0002-4037-7158)
- Tianyi Wang (ORCID: https://orcid.org/0000-0002-8860-0400)
- Kang An (ORCID: https://orcid.org/0000-0003-4937-4567)
- Yang Liu (ORCID: https://orcid.org/0000-0003-0820-0683)
- Jing Zhang (ORCID: https://orcid.org/0000-0001-8861-7336)
- Chengjuan Luo
- Jing Yang (ORCID: https://orcid.org/0009-0004-7774-6123)
- Zetong Zhou
- Long-Jun Gu
- Wenjie Li (ORCID: https://orcid.org/0000-0003-3523-0458)
Institutions
- Shanghai Children's Medical Center (CN)
Funders
- National Natural Science Foundation of China
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China